Further, we recently showed that antagonizing the PD-1 receptor during prophylactic immunization with an adenovirus-based or radiation-attenuated sporozoite-based malaria vaccine significantly enhanced the number of antigen-specific CD8+ T cells (Kotraiah et al., 2020; Phares et al., 2020). Here, CD8A is linked to malaria.